91 related articles for article (PubMed ID: 24501813)
1. [Tobacco--once a medicinal plant. Does it contain substances with medicinal properties?].
Budzianowski J
Przegl Lek; 2013; 70(10):865-8. PubMed ID: 24501813
[TBL] [Abstract][Full Text] [Related]
2. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
Castagnoli K; Murugesan T
Neurotoxicology; 2004 Jan; 25(1-2):279-91. PubMed ID: 14697903
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
Khalil AA; Davies B; Castagnoli N
Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.
Castagnoli KP; Steyn SJ; Petzer JP; Van der Schyf CJ; Castagnoli N
Chem Res Toxicol; 2001 May; 14(5):523-7. PubMed ID: 11368550
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of monoamine oxidase B in the brains of smokers.
Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Shea C; Schlyer D; Wolf AP; Warner D; Zezulkova I; Cilento R
Nature; 1996 Feb; 379(6567):733-6. PubMed ID: 8602220
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic receptors as CNS targets for Parkinson's disease.
Quik M; Bordia T; O'Leary K
Biochem Pharmacol; 2007 Oct; 74(8):1224-34. PubMed ID: 17631864
[TBL] [Abstract][Full Text] [Related]
7. Can nicotine be used medicinally in Parkinson's disease?
Thiriez C; Villafane G; Grapin F; Fenelon G; Remy P; Cesaro P
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):429-36. PubMed ID: 22114853
[TBL] [Abstract][Full Text] [Related]
8. Does nicotine have beneficial effects in the treatment of certain diseases?
Birtwistle J; Hall K
Br J Nurs; 1996 Oct 24-Nov 13; 5(19):1195-202. PubMed ID: 9006184
[TBL] [Abstract][Full Text] [Related]
9. A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke.
Hong SW; Teesdale-Spittle P; Page R; Truman P
Neurotoxicology; 2022 Dec; 93():163-172. PubMed ID: 36155069
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease.
Pauly JR; Charriez CM; Guseva MV; Scheff SW
Ann N Y Acad Sci; 2004 Dec; 1035():316-34. PubMed ID: 15681815
[TBL] [Abstract][Full Text] [Related]
11. Nicotine neuroprotection against nigrostriatal damage: importance of the animal model.
Quik M; O'Neill M; Perez XA
Trends Pharmacol Sci; 2007 May; 28(5):229-35. PubMed ID: 17412429
[TBL] [Abstract][Full Text] [Related]
12. Nicotine and nicotinic receptors; relevance to Parkinson's disease.
Quik M; Kulak JM
Neurotoxicology; 2002 Oct; 23(4-5):581-94. PubMed ID: 12428730
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring neuronal NO-synthase inactivators found in Nicotiana tabacum (Solanaceae) and other plants.
Lowe ER; Everett AC; Lau M; Dunbar AY; Michener D; Osawa Y
Phytomedicine; 2007 May; 14(5):344-52. PubMed ID: 17084601
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.
Park HJ; Lee PH; Ahn YW; Choi YJ; Lee G; Lee DY; Chung ES; Jin BK
Eur J Neurosci; 2007 Jul; 26(1):79-89. PubMed ID: 17581257
[TBL] [Abstract][Full Text] [Related]
15. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.
Unzeta M; Sanz E
Int Rev Neurobiol; 2011; 100():217-36. PubMed ID: 21971010
[TBL] [Abstract][Full Text] [Related]
16. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
17. Nicotine as a potential neuroprotective agent for Parkinson's disease.
Quik M; Perez XA; Bordia T
Mov Disord; 2012 Jul; 27(8):947-57. PubMed ID: 22693036
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type.
Lewis AJ; Truman P; Hosking MR; Miller JH
Tob Control; 2012 Jan; 21(1):39-43. PubMed ID: 21636610
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration.
Castagnoli K; Petzer JB; Steyn SJ; van der Schyf CJ; Castagnoli N
Inflammopharmacology; 2003; 11(2):183-8. PubMed ID: 15035820
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents.
Ward RJ; Lallemand F; de Witte P; Dexter DT
Prog Neurobiol; 2008 Jun; 85(2):135-47. PubMed ID: 18482793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
